Showing results (271-280 of 307) with videos related to
Sort By:
Pageof 31
The Journal of Pediatrics|October 23, 2003
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based studySubra Kugathasan, Robert H Judd, Raymond G Hoffmann, et al.Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.Cancer Immunology Research|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult SubjectsFrancesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.Journal of Neuropathology and Experimental Neurology|September 9, 2021
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy PatientsSilvia Torelli, Domenic Scaglioni, Valentina Sardone, et al.Journal of Infection and Public Health|September 23, 2025
Methods and tools for rapid risk assessments for acute public health emergenciesNaif Khalaf Alharbi, Lubna Alariqi, Jas Mantero, et al.ACS Infectious Diseases|December 9, 2020
Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide SynthaseJohn G M Mina, Rebecca L Charlton, Edubiel Alpizar-Sosa, et al.Nature Medicine|July 13, 2021
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysisNicholas A Vitanza, Adam J Johnson, Ashley L Wilson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid TumorsNavin Pinto, Catherine M Albert, Mallory R Taylor, et al.Journal of Hematology Oncology Pharmacy|September 6, 2024
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy ActivitiesNicholas A Vitanza, Michelle Choe, Christopher Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.Pageof 31